Clinical Trials Directory

Trials / Completed

CompletedNCT01692015

Diet and Hereditary Haemorrhagic Telangiectasia

A Questionnaire Study on Diet and Hereditary Haemorrhagic Telangiectasia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hereditary Haemorrhagic Telangiectasia (HHT) affects 1 in 5,000 people. The purpose of this study is to provide data regarding the diet and nosebleed frequency using a questionnaire. This will be filled in by people with HHT. The questionnaire has been designed in paper format.

Detailed description

Hereditary Haemorrhagic Telangiectasia (HHT) affects 1 in 5,000 people, usually causing nosebleeds, skin blood spots, and/or anaemia as a result of bleeding from the nose or gut. The majority of people with HHT also have abnormal blood vessels (arteriovenous malformations) in internal organs such as the lungs, liver and brain. Management of this multisystem disorder is highly challenging. The Lead Applicant has spent 20 years working on this rare disease, and identified multiple areas where more evidence is required to assist clinicians and patients with this lifelong condition. A particular issue is whether the diet influences HHT or its complications in any way. In this study, people will fill in two questionnaires, one giving details of their diet, and another details of their nosebleeds. They will also be asked to consider participating in an accessory study arm which includes weighing food for one week and providing a food diary, in addition to having a single set of blood test.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire on dietary history
OTHERQuestionnaire on nosebleed severity
OTHEROne week food diary generated by weighing foods
PROCEDUREBlood tests for full blood count, albumin, and indices of nutritional status

Timeline

Start date
2011-04-01
Primary completion
2013-09-01
Completion
2016-09-01
First posted
2012-09-25
Last updated
2024-03-29
Results posted
2024-03-29

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01692015. Inclusion in this directory is not an endorsement.